Bitget to invest in Indian Blockchain Startups To Support the On-going Crypto Adoption Wave
VICTORIA, Seychelles, Nov. 6, 2023 /PRNewswire/ — Bitget, the leading cryptocurrency derivatives and copy trading platform, has announced its strategic plans of investing in blockchain startups based in India, under its Blockchain4Youth (B4Y) $10 million Web3-focused project. The initiative k
NATIONAL SUMMIT TO TACKLE URGENT NEED FOR COMPREHENSIVE CAREGIVING STRATEGY
Canadian Centre for Caregiving Excellence Convenes Canadian and International Experts in Ottawa to Support Caregivers OTTAWA, ON, Nov. 6, 2023 /CNW/ – WORKING TOGETHER: THE CANADIAN CAREGIVING SUMMIT, organized by the Canadian Centre for Caregiving Excellence (CCCE), starts today to chart a
Key Players in the Vegetable Oil Market Include Archer-Daniels Midland, Wilmar, and Cargill
DUBLIN, Nov. 6, 2023 /PRNewswire/ — The “Global Vegetable Oil Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” report has been added to ResearchAndMarkets.com’s offering. The global vegetable oil
Volition and VPG Launch Nu.Q® Vet Cancer Test in UK & Ireland
HENDERSON, Nev., Nov. 6, 2023 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, and Veterinary Pathology Group (VPG), a leading high quality diagnostic laboratory, have joined forces to launch the Nu.Q® Vet Cancer Test to
Cellenkos® Announces Oral Presentation and Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition
Oral presentation highlights the resolving of inflammation and superior homing to bone marrow of CXCR4-enriched T regulatory cells.Poster presentation includes safety and efficacy data from phase 1b LIMBER-TREG108 study evaluating CK0804, CXCR4 enriched, T regulatory cells, as an add on therapy to
Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission
Primary endpoint and all key secondary endpoints met with high statistical significance in GLOW study.With 6-month dosing of all patients, tarcocimab and the ABC platform continue to demonstrate differentiated durability.Following dialogue with US regulatory authorities, Kodiak plans to conduct one
Markel strengthens its distribution team with digital & portfolio expertise
LONDON, Nov. 6, 2023 /PRNewswire/ — Markel, the insurance operation within Markel Group Inc. (NYSE: MKL), has appointed Chris Conyard as Digital & Portfolio Executive in its distribution strategies and business development (DS&BD) team. In his new position, Conyard will work closely wi
CLAIMS PROCESS BEGINS FOR DISTRIBUTION OF SETTLEMENT FUNDS IN DIAMONDS CLASS ACTION
VANCOUVER, BC, Nov. 6, 2023 /CNW/ – The claims process for the Diamonds class action is about to begin. Did you purchase a Gem Grade Diamond in Canada between January 1, 1994 and October 14, 2016? Camp Fiorante Matthews Mogerman LLP (“CFM”), Siskinds LLP, and Consumer Law Group I
DigiFabster and Materialise Collaborate to Integrate E-Commerce and Quoting Solution into Additive Manufacturing Workflow
DigiFabster, a quoting automation and e-commerce solution for advanced manufacturing companies, and Materialise, a global leader in 3D printing software and service solutions, announced a collaboration to connect DigiFabster’s automated quoting and eCommerce solution with Materialise CO-AM, an
DanAds Empowers Nine with Revolutionary Self-Serve Ad Platform: Nine Ad Manager
NEW YORK, Nov. 6, 2023 /PRNewswire/ — DanAds proudly announces the launch of Nine Ad Manager, a self-serve advertising platform that leverages Artificial Intelligence (AI) to empower Australian small and medium-sized businesses (SMBs) with the capability to purchase video advertising on 9Now,